Pitt BioForge Announces Successful Completion of Advanced Manufacturing of Microarray Patches with Panther Life Sciences ...

The Global MiRNA Microarray Kits And Reagents Market is projected to grow at a CAGR of 8.5% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that ...

Blue Shield of California today announced two new senior executive leaders who will play critical roles in the organization's ...

Seasoned global pharmaceutical executive, Mr Brent MacGregor, joins Vaxxas Board to accelerate self-administered HD-MAP vaccines for global ...

Terray Therapeutics Announces EMMI, AI and Experimentation Platform, and Selection Models that save time and cost in Drug ...

New studies reveal that optical genome mapping (OGM) can detect chromosomal abnormalities linked to recurrent pregnancy loss, ...

Bionano Genomics, Inc. (NASDAQ: BNGO) Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats ...

Microarray testing can only be performed on an amniocentesis or CVS. These tests are more advanced than NIPT and are capable of looking at chromosomes to find out if any of them are missing a small ...

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...

Researchers at Dartmouth–Hitchcock Medical Center investigated whether OGM could detect harmful chromosomal changes in patients with a family history or risk of recurrent pregnancy loss who had ...

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...